Vascular Biogenics Ltd. - Ordinary Shares (VBLT) Social Stream
VASCULAR BIOGENICS LTD (VBLT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VBLT.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-04-12 | 4 | $7 | $4 | $5.875 | $0.156 | 3666.03% |
2022-05-17 | 5 | $7 | $4 | $5.875 | $0.156 | 3666.03% |
2022-05-18 | 4 | $7 | $4 | $5.5 | $0.156 | 3425.64% |
NA | 1 | $NA | $NA | $NA | $0.156 | NA% |
The Trend in the Analyst Price Target
VBLT's average price target has moved up $0.5 over the prior 12 months.
500 - Internal server error
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|
VBLT Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 21 months, VBLT's average broker recommendation rating worsened by 0.5.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VBLT as an investment opportunity.
- In terms of how VASCULAR BIOGENICS LTD fares relative to all US stocks, note that its number of analysts covering the stock is higher than 95.56% of that group.
- In terms of how VASCULAR BIOGENICS LTD fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 496.97% of that group.
- In terms of how VASCULAR BIOGENICS LTD fares relative to Healthcare stocks, note that its average analyst price target is higher than 45.24% of that group.
- In the context of stocks in the micro market cap category, VASCULAR BIOGENICS LTD's variance in analysts' estimates is lower than -174.7% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VASCULAR BIOGENICS LTD are CANF, BLRX, and GLMD.
View All Top Stocks by Price Target
Is VBLT a Buy, Hold or Sell? See the POWR Ratings now!